Morpholine

Morpholine

SCHEMBL10535616

C1COCCN1.CC(CC(=O)O)C(=O)c1ccc(-n2ccnc2)nc1

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 5/20 0.41
▸ CYP1A2 P05177 4/20 0.41
▸ CYP2D6 P10635 4/20 0.41
▸ CYP2C19 P33261 3/20 0.41
▸ CYP2C9 P11712 2/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ MGLL Q99685 1/20 0.34
▸ NAMPT P43490 2/20 0.34
▸ CTSA P10619 1/20 0.34
▸ ALOX15 P16050 2/20 0.33
▸ HSD17B10 Q99714 2/20 0.33
▸ CLK4 Q9HAZ1 2/20 0.33
▸ KCNJ1 P48048 1/20 0.33
▸ BAZ2B Q9UIF8 1/20 0.33
▸ ADRB1 P08588 1/20 0.33
▸ APEX1 P27695 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ CD38 P28907 1/20 0.33
▸ ADH5 P11766 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10550020 0.89 CYP3A4 (0.50) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL10468098 0.78 ALDH1A1 (0.44) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL10625333 0.73 CYP3A4 (0.58) CYP3A4KMT2ABAZ2BADH5MAOB
SCHEMBL10549444 0.70 SMN1; SMN2 (0.40) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL600477 0.70 CYP3A4 (0.61) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL1976009 0.69 CYP3A4 (0.62) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL30317655 0.69 CYP3A4 (0.62) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL10469495 0.68 CYP3A4 (0.54) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL5280849 0.66 CYP3A4 (0.60) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9
SCHEMBL8297460 0.66 CYP3A4 (0.56) CYP3A4CYP1A2CYP2D6CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1989008108-A1 PYRIDYL-PYRIDAZINONE AND PYRIDYL-PYRAZOLINONE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CONGESTIVE HEART FAILURE RORER INTERNATIONAL (OVERSEAS) INC. (US) 1989-09-08 — — WO disclosed
Send feedback